These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2093839)

  • 1. Fluconazole in the treatment of oropharyngeal candidosis in HIV-positive patients.
    Just-Nübling G; Gentschew G; Döhle M; Böttinger C; Helm EB; Stille W
    Mycoses; 1990; 33(9-10):435-40. PubMed ID: 2093839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed oropharyngeal candidiasis due to Candida albicans and non-albicans Candida strains in HIV-infected patients.
    Dronda F; Alonso-Sanz M; Laguna F; Chaves F; Martínez-Suárez JV; Rodríguez-Tudela JL; González-López A; Valencia E
    Eur J Clin Microbiol Infect Dis; 1996 Jun; 15(6):446-52. PubMed ID: 8839637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between antifungal susceptibility testing of Candida isolates from patients with HIV infection and clinical results after treatment with fluconazole.
    Ruhnke M; Eigler A; Engelmann E; Geiseler B; Trautmann M
    Infection; 1994; 22(2):132-6. PubMed ID: 8070927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
    Barchiesi F; Arzeni D; Del Prete MS; Sinicco A; Falconi Di Francesco L; Pasticci MB; Lamura L; Nuzzo MM; Burzacchini F; Coppola S; Chiodo F; Scalise G
    J Antimicrob Chemother; 1998 May; 41(5):541-8. PubMed ID: 9630407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection.
    Tumbarello M; Caldarola G; Tacconelli E; Morace G; Posteraro B; Cauda R; Ortona L
    J Antimicrob Chemother; 1996 Oct; 38(4):691-9. PubMed ID: 8937963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluconazole in the management of oropharyngeal candidosis in a predominantly HIV antibody-positive group of patients.
    Dupont B; Drouhet E
    J Med Vet Mycol; 1988 Feb; 26(1):67-71. PubMed ID: 2837559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oropharyngeal candidiasis resistant to fluconazole in patients infected by HIV].
    Drobacheff C; Manteaux A; Millon L; Reboux G; Barale T; Laurent R
    Ann Dermatol Venereol; 1996; 123(2):85-9. PubMed ID: 8761757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
    Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
    Saag MS; Fessel WJ; Kaufman CA; Merrill KW; Ward DJ; Moskovitz BL; Thomas C; Oleka N; Guarnieri JA; Lee J; Brenner-Gati L; Klausner M
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1413-7. PubMed ID: 10555103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
    Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
    Vazquez JA; Skiest DJ; Nieto L; Northland R; Sanne I; Gogate J; Greaves W; Isaacs R
    Clin Infect Dis; 2006 Apr; 42(8):1179-86. PubMed ID: 16575739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Candida albicans morphotypes and in vitro adhesivity to cells of the human oral mucosa in HIV-positive and AIDS patients after exposure of blastospores to fluconazole. II].
    Spadari E; Arosio M; Malighetti V; Bellotti MG; Artini MZ; Spadari F; Riviera L
    Minerva Stomatol; 1998; 47(7-8):293-7. PubMed ID: 9793362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of oropharyngeal candidiasis in HIV-infected children with oral fluconazole. Multicentre Study Group [corrected].
    Marchisio P; Principi N
    Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):338-40. PubMed ID: 8070442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative growth measurement of Candida species in a single concentration of fluconazole predicts the clinical response to fluconazole in HIV infected patients with oral candidosis.
    Cartledge JD; Midgley J; Gazzard BG
    J Antimicrob Chemother; 1996 Feb; 37(2):275-83. PubMed ID: 8707737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of the efficacy of fluconazole and amphotericin B in the treatment of oropharyngeal candidosis in patients undergoing radiotherapy for head and neck tumours.
    Finlay PM; Richardson MD; Robertson AG
    Br J Oral Maxillofac Surg; 1996 Feb; 34(1):23-5. PubMed ID: 8645677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point prevalence, microbiology and fluconazole susceptibility patterns of yeast isolates colonizing the oral cavities of HIV-infected patients in the era of highly active antiretroviral therapy.
    Barchiesi F; Maracci M; Radi B; Arzeni D; Baldassarri I; Giacometti A; Scalise G
    J Antimicrob Chemother; 2002 Dec; 50(6):999-1002. PubMed ID: 12461023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluconazole response patterns in HIV-infected patients with oropharyngeal candidiasis.
    Diz Dios PD; Alvarez Alvarez J; Fernández Feijoo J; Castro Ferreiro M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Feb; 79(2):170-4. PubMed ID: 7614179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology.
    Maenza JR; Merz WG; Romagnoli MJ; Keruly JC; Moore RD; Gallant JE
    Clin Infect Dis; 1997 Jan; 24(1):28-34. PubMed ID: 8994752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of HIV-related fluconazole-resistant oral candidosis with D0870, a new triazole antifungal.
    Cartledge JD; Denning DW; Dupont B; Clumeck N; De Wit S; Midgley J; Hawkins DA; Gazzard BG
    AIDS; 1998 Mar; 12(4):411-6. PubMed ID: 9520171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.